RecruitingNCT07115329
Zelquistinel or placebo for depression symptoms
About this title
Read the official source — NCT07115329Medication studyAges 18–64United States
Understand this study
Who could participate?
Listed age limits: 18 years to 64 years.
What will I do during this study?
You are randomly assigned to take either zelquistinel or a matching placebo (an inactive comparison treatment) tablet by mouth once a week for six weeks. The study evaluates symptoms of depression and safety during treatment.
- Listed locations
- Phoenix and 31 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 5, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 164
- Sponsor
- Syndeio Biosciences, Inc
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT07115329
- Official title
Show the full official title
Phase 2, Multicenter, Randomized, Double-Blind Evaluation of the Efficacy and Safety of Oral GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Phoenix · Tucson · Montclair
27 more locations
- Oceanside
- Redlands
- San Francisco
- San Jose
- Walnut Creek
- Jacksonville
- Miami
- Naples
- Riverview
- West Palm Beach
- Stone Mountain
- Chicago
- Metairie
- Rockville
- Towson
- Worcester
- Rochester Hills
- Cedarhurst
- New York
- Raleigh
- Independence
- Allentown
- Moosic
- Philadelphia
- Franklin
- Atascocita
- DeSoto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Syndeio Biosciences, Inc.
Does this study involve medication?
Yes. The study involves medication, including Zelquistinel.
Who can participate?
Listed age limits: 18 years to 64 years.
Is this study still recruiting?
The registry lists this study as recruiting.
